Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Hansmann

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
Blood|August 26, 2010
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHLGerman Ott, Marita Ziepert, Wolfram Klapper, et al.
Leukemia|September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHLAnnette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupAnnette M Staiger, Marita Ziepert, Heike Horn, et al.
Leukemia & Lymphoma|August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYCUlrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
Nature Communications|May 20, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Journal of Hematopathology|August 12, 2009
Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approachAnke van Rijk, David Mason, Margaret Jones, et al.
Blood|June 12, 2025
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRSTMaximilian Merz, Nico Gagelmann, Samih Smaili, et al.
Ejhaem|September 2, 2022
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigensTheresa Bock, Moritz Bewarder, Onur Cetin, et al.
Genome Medicine|May 2, 2019
A modular transcriptome map of mature B cell lymphomasHenry Loeffler-Wirth, Markus Kreuz, Lydia Hopp, et al.
Molecular Cancer Research : MCR|January 29, 2017
Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell SarcomasMaria Antonella Laginestra, Claudio Tripodo, Claudio Agostinelli, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Blood|August 26, 2010
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHLGerman Ott, Marita Ziepert, Wolfram Klapper, et al.
Leukemia|September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHLAnnette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupAnnette M Staiger, Marita Ziepert, Heike Horn, et al.
Leukemia & Lymphoma|August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYCUlrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
Nature Communications|May 20, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Journal of Hematopathology|August 12, 2009
Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approachAnke van Rijk, David Mason, Margaret Jones, et al.
Blood|June 12, 2025
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRSTMaximilian Merz, Nico Gagelmann, Samih Smaili, et al.
Ejhaem|September 2, 2022
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigensTheresa Bock, Moritz Bewarder, Onur Cetin, et al.
Genome Medicine|May 2, 2019
A modular transcriptome map of mature B cell lymphomasHenry Loeffler-Wirth, Markus Kreuz, Lydia Hopp, et al.
Molecular Cancer Research : MCR|January 29, 2017
Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell SarcomasMaria Antonella Laginestra, Claudio Tripodo, Claudio Agostinelli, et al.
Pageof 26